Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Inolitazone

SKU: orb1308191

Description

Inolitazone

Research Area

Metabolism Research, Molecular Biology

Images & Validation

Key Properties

CAS Number223132-37-4
MW502.58
Purity99.58% (May vary between batches)
FormulaC27H26N4O4S
SMILESCN1C=2C(N=C1COC3=CC=C(CC4C(=O)NC(=O)S4)C=C3)=CC=C(OC5=CC(C)=C(N)C(C)=C5)C2
TargetPPAR
SolubilityDMSO:55 mg/mL (109.44 mM)

Bioactivity

In Vivo
In athymic nude mice prior to DRO tumor cell implantation, Inolitazone inhibits tumor growth in a dose responsive fashion. 0.025% Inolitazone inhibits growth on day 32 by 94.4%. In the 0.0025% treatment group, tumor growth is inhibited by 62.3% while the 0.00025% dose demonstrated no growth inhibitory activity as compared to control. Inolitazone treated animals demonstrate tumor growth inhibition of 68.9% in DRO tumors and 48.3% in ARO tumors on day 35. Inolitazone plus Paclitaxel demonstrate additive antiproliferative activity in cell culture and minimal ATC tumor growth.
In Vitro
Inolitazone (10 nM) inhibits the growth of DRO cells through a PPARγ-dependent mechanism. Inolitazone upregulates the cell cycle kinase inhibitor, p21WAF1/CIP1. Inolitazone (10 nM) activates PPARγ:RXRα-dependent transcription utilizing a PPRE response element fused to a luciferase reporter gene (PPRE3-tk-luc). Inolitazone specifically activates PPARγ, but not PPARα or PPARδ. Inolitazone (10 nM) following transient transfection with the appropriate PPAR isoform (γ, α, or δ) and PPAR response element linked to a luciferase reporter in RIE rat small intestinal cell line, which does not express PPARs, yields increased luciferase activity only in the presence of PPARγ and PPRE3-tk-luc.

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

RS 5444, RS5444, RS-5444, PPAR, PPARγ, Peroxisome proliferator-activated receptors, inhibit, Efatutazone, Inolitazone, Inhibitor, CS7017, CS-7017, CS 7017

Similar Products

Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Protocol Information

Available Sizes

Select a size below

500 mg
1 mg
$ 110.00
5 mg
$ 200.00
1 ml x 10 mM (in DMSO)
$ 240.00
10 mg
$ 300.00
25 mg
$ 460.00
50 mg
$ 640.00
100 mg
$ 840.00